April 17, 2013 ·
Leave a comment
Industry Insights from Paul Meade, M.Sc, MPH
Allison Murphy and I had the pleasure of participating in the MSL Society’s inaugural global conference and gala in Philadelphia earlier this month. At Thought Leader Select, we always enjoy the opportunity to meet some of our great colleagues in medical affairs in the pharmaceutical, biotechnology, and device industries, but this event proved to be really special.
Since joining our company last year, Allison has continued to make a real impact in the medical affairs community. After serving much of the last decade in Eli Lilly’s medical affairs division in support of the company’s endocrinology portfolio, Allison has brought a wealth of medical affairs expertise to Thought Leader Select. This expertise has continued to evolve, even as a consultant, through her membership and advisory board participation with the MSL Society, a dynamic group that we are proud to support as a company.
Dr. Samuel Dyer, the founder and head of the MSL Society, approached us a few months ago, asking for help with the burgeoning organization’s first global event. As a veteran of the industry myself, I have participated in many events through the years, as a participant, speaker, and sponsor. I must admit that I was more than a little skeptical about another conference/event series emerging in a space with ... read more »
TAGS: 
Allison Murphy Bayer biotechnology clinical trials CROs David Cram diagnostics Eli Lilly Global Prairie key opinion leaders in medicine KOL collaborations KOL engagement KOL strategy medical affairs medical devices medical science liaisons Mitch Trujillo MSL Society MSL Society Global Conference and Gala MSLs Paul Meade pharmaceuticals Quintiles Samuel Dyer Stewart Rosen Thought Leader Select thought leaders in medicine
February 7, 2013 ·
Leave a comment
For Immediate Release
February 7, 2013 (Chapel Hill, NC) The Medical Science Liaison Society (MSL Society) is planning its first global conference and gala for April 2013.
The event will take place at Philadelphia’s Hyatt at the Broadview on South Broad Street, from April 1-3. The 2013 MSL Society Conference and Gala is the first event of its kind, a tangible extension of the non-profit organization’s mission to bring together global medical affairs professionals for education and networking in an effort to support the profession.
Attendees will include Medical Affairs and MSL Leadership, as well as other professionals focusing on key topic including KOL access, HEOR, clinical trials, clinical investigation, key opinion leader relationship management, and medical communications. The emerging roster of speakers includes luminaries from the world of medical affairs, including Dr. Stewart Rosen, Vice President of Medical Affairs at Quintiles, Dr. Robert Ang, Vice President of Medical Affairs at Cadence Pharmaceuticals, and Dr. Elizabeth Kupferer, Director of Medical Affairs at Sequenom. 
Highlights of the three-day event include a welcome reception on day one, followed by a full day of education and networking, the gala dinner to culminate day two, and a final round of education and networking on day three.
“We’ve planned our first live conference with the needs ... read more »
TAGS: Allison Murphy biotechnology Cadence Pharmaceuticals clinical investigation clinical trials Elizabeth Kupferer HEOR key opinion leaders KOL management KOLs Kristen Smithwick medical affairs medical affairs education medical affairs networking medical devices medical science liaisons MSL leadership MSL Society MSL Society Global Conference and Gala patient health pharmaceuticals public health Quintiles Robert Ang Samuel Dyer Sequenom Stewart Rosen Thought Leader Select thought leaders in medicine
November 15, 2012 ·
Leave a comment
The Medical Science Liaison Society, a non-profit focused on advancing the Medical Science Liaison career in the pharmaceutical, biotechnology, and medical device industries, has named Thought Leader Select’s Allison Murphy to its global advisory committee.
The MSL Society, led by Dr. Samuel Dyer from its Florida headquarters, is bringing the global MSL community together through a variety of educational and networking platforms, including webinars, white papers, conferences, and multiple social media outlets. Dr. Dyer and the MSL Society team of advisors are collaborating with several premier industry partners, including First Word Reports and EyeforPharma.
Prior to joining Thought Leader Select as a global sales consultant in 2012, Murphy spent the previous decade of her career working as a Medical Science Liaison at Eli Lilly and Company in the therapeutic area of Endocrinology. Murphy collaborated with multiple Key Opinion Leaders to drive Lilly’s medical initiatives in support of products aimed at treating conditions ranging from diabetes to growth disorders.
“I am very proud to be a part of the MSL Society’s global advisory committee,” stated Murphy. “I know first-hand from my days at Lilly that there weren’t enough of the right resources and networking opportunities for MSLs and Medical Affairs executives, to help them advance their careers and ... read more »
TAGS: Allison Murphy biotechnology diabetes Eli Lilly and Company endocrinology EyeforPharma First Word Reports growth disorders key opinion leaders medical affairs medical devices Medical Science Liaison Society medical science liaisons MSL education MSL networking MSL resources MSLs pharmaceuticals Samuel Dyer Thought Leader Select
October 30, 2012 ·
Leave a comment
Thought Leader Select is a company focused on driving industry collaborations among biopharmaceutical, medical device, and diagnostics companies with leading medical experts and centers of excellence, with the ultimate goals of these collaborations being two-fold in purpose: better treatment options for patients and better outcomes for global public health. As part of our company’s mission, we work with multiple organizations to promote best practices that deliver ethical, transparent interactions among these various healthcare constituencies.
One of these groups is the recently-launched Medical Science Liaison Society, a global Non-Profit organization being led by the Chairman of the Board, Dr. Samuel Dyer. The MSL Society is filling a vital need for the expanding role of Medical Science Liaisons around the world, as they collaborate with KOLs, physicians, and other health care professionals to advance medical science together to improve the quality of life for patients everywhere.
Thought Leader Select’s Allison Murphy, a veteran MSL herself from her days working in the Endocrinology Medical Affairs unit at Eli Lilly and Company, recently sat down with Dr. Dyer to learn more about this emerging organization and the impact the MSL Society is having in promoting the role of Medical Science Liaisons in the pharmaceutical, biopharmaceutical, medical device, and diagnostics industries.
In ... read more »
TAGS: Allison Murphy biotechnology centers of excellence CRO Eli Lilly and Company health care professionals healthcare key opinion leader management key opinion leader relationships key opinion leaders KOLs medical affairs medical affairs conference medical device medical science Medical Science Liaison Society medical science liaisons MSL and Medical Affairs Networking Group LinkedIn MSL best practices MSL conferences MSL education MSL executives MSL experts MSL management MSL resources MSL World group LinkedIn off-label discussions pharmaceutical physicians publications Samuel Dyer scientific journals social media Thought Leader Select University of North Carolina at Chapel Hill School of Medicine
October 25, 2012 ·
Leave a comment
Thought Leader Select is a company focused on driving industry collaborations among biopharmaceutical, medical device, and diagnostics companies with leading medical experts and centers of excellence, with the ultimate goals of these collaborations being two-fold in purpose: better treatment options for patients and better outcomes for global public health. As part of our company’s mission, we work with multiple organizations to promote best practices that deliver ethical, transparent interactions among these various healthcare constituencies.
One of these groups is the recently-launched Medical Science Liaison Society, a global Non-Profit organization being led by the Chairman of the Board, Dr. Samuel Dyer. The MSL Society is filling a vital need for the expanding role of Medical Science Liaisons around the world, as they collaborate with KOLs, physicians, and other health care professionals to advance medical science together to improve the quality of life for patients everywhere.
Thought Leader Select’s Allison Murphy, a veteran MSL herself from her days working in the Endocrinology Medical Affairs unit at Eli Lilly and Company, recently sat down with Dr. Dyer to learn more about this emerging organization and the impact the MSL Society is
having in promoting the role of Medical Science Liaisons in the pharmaceutical, biopharmaceutical, medical device, and diagnostics industries.
Allison Murphy: ... read more » TAGS: Allison Murphy biopharmaceutical companies centers of excellence diagnostics companies Eli Lilly and Company EyeforPharma First Word global MSL community key opinion leader management key opinion leader relationships KOL compliance L&M Association Management medical affairs medical affairs executives medical device companies medical experts Medical Science Liaison Society medical science liaisons MSL conferences MSL podcasts MSL webinars MSL white papers non-profit association pharmaceutical industry Samuel Dyer Thought Leader Select
April 26, 2012 ·
Leave a comment
April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for the treatment of infectious diseases, approached Thought Leader Select for support with its development pipeline across the Canadian market. To meet the combined strategic needs of the company’s emerging pipeline in treating conditions like HIV and Hepatitis-C, Thought Leader Select will deploy its in-house research group for a multi-disciplinary assessment of the key opinion leader community in infectious diseases.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following areas:
Gastroenterology
Hepatology
Infectious Disease
Internal Medicine
For the first wave of the assessment, the Thought Leader Select research group will identify 50 physicians appropriate for compliant engagement in support of drug development for infectious diseases, across multiple Canadian provinces.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought leaders, ... read more »
TAGS: basic and clinical research biopharmaecutical consulting firm diagnostics drug development gastroenterology geographic impact of key opinion leaders health care professionals Hepatitis C hepatology HIV infectious diseases internal medicine key opinion leader relationships key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOL strategy Kristen Smithwick market access medical affairs medical device medical marketing medical meetings speakers patient health payer marketing physicians pipeline planning pricing and reimbursement professional network mapping public health scientific journal publishing Thought Leader Select thought leaders in medicine treatment guidelines
November 2, 2010 ·
1 comment
Lisa Smith helped to start Thought Leader Select in 2006 with Paul Meade and Kristen Smithwick. As Executive Vice President of Research and Development, Lisa ensures the company’s highest research standards. She has years of experience leading research and consulting projects for the biopharmaceutical, diagnostic and healthcare industries. Through her work, Lisa has helped scores of companies improve thought leader engagement strategies and strengthen medical affairs, commercial and clinical development functions.
The Thought Leader Select Blog sat down with Lisa, the bedrock of Thought Leader Select’s industry-leading research, to learn more about her role within the company, what drives her at work and the extracurricular passions that make her unique.
TLS Blog: Good morning, Lisa. Why did you help to found Thought Leader Select?
Lisa Smith: I was working at Clear Point Health with Paul Meade on a variety of interesting projects for biopharmaceutical clients. One client, in particular, needed our help to understand how to make advisory boards more effective. Paul and I interviewed executives in several pharmaceutical companies and key opinion leaders to identify best practices in developing, planning and executing effective advisory board meetings. This work sparked our interest in thought leader engagement. Following our work on advisory board best practices, Paul and I helped the same client better engage a group of KOLs by devising an organized system ... read more »
TAGS: advisory boards best practices biopharmaceutical Clear Point Health commercial development ethics healthcare journalism key opinion leaders KOL strategies KOLs Lisa Smith medical affairs OIG Paul Meade public health research thought leader leader engagement Thought Leader Select thought leaders transparency
May 11, 2010 ·
Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for ... read more »
TAGS: biopharmaceutical biotechnology certificate Civil Air Patrol Clear Point Health clinical operations clinical researchers Gillings School of Global Public Health GlaxoSmithKline healthcare ethics healthcare policy healthcare research key opinion leaders KOL deployment KOL development KOL engagement KOL identification KOL profiling KOLs marketing planning master of public health medical affairs Merck nurses Paul Meade pharmaceutical pharmacists physician assistants physicians predictive medicine public health ethics Public Health Leadership Program research and development Thought Leader Select United States Air Force University of North Carolina at Chapel Hill veterinarians
